A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

Table 1 Description of patient samples used for IHC analysis

Sample no.	Diagnosis	FIGO stage	Age	Pre-operative CA125	Survival
Normal
1	Normal ovarian epithelium	-	NA	-	-
2	Normal ovarian epithelium	-	61	-	-
3	Normal ovarian epithelium	-	69	-	-
4	Normal ovarian epithelium	-	65	-	-
5	Normal ovarian epithelium	-	62	-	-
6	Normal ovarian epithelium	-	NA	-	-
Borderline
1	Serous cystadenocarcinoma	Ib	50	12	4 years 10 months ALC
2	Serous cystadenocarcinoma	Ic	31	117	4 years 9 months^a
3	Serous cystadenoma	Ia	60	1237	5 years ALC
4	Serous cystadenoma	Ic	32	34	4 years 8 months^a
5	Papillary serous cystadenocarcinoma	Ia	47	NA	5 years 8 months ALC
Grade 2
1	Papillary serous cystadenocarcinoma	IIIc	71	NA	8 months ALC
2	Papillary serous cystadenocarcinoma	IIIc	43	428	3 years 7 months until death
3	Papillary serous cystadenocarcinoma	IIIc	52	309	10 months ALC
4	Papillary serous cystadenocarcinoma	IV	58	3187	6 years 1 months ALC
5	Papillary serous cystadenocarcinoma	IIIc	41	NA	8 years 8 months^a
6	Serous cystadenoma NOS	IIIc	49	463	2 years 7 months^a
7	Serous cystadenoma NOS	IIIa	64	1404	7 months ALC
Grade 3
1	Papillary serous cystadenoma	IIIc	75	1443	4 yrs^a
2	Papillary serous cystadenocarcinoma	IIc	67	24	2 months ALC
3	Serous cystadenocarcinoma NOS	IIIc	55	3025	2 years 5 months until death
4	Serous cystadenocarcinoma NOS	IIIc	59	4224	1 year 4 months until death
5	Serous cystadenocarcinoma NOS	IIIc	76	130	3 years 6 months^a
6	Serous cystadenocarcinoma NOS	IIc	60	107	3 years 6 months^a
7	Serous cystadenocarcinoma NOS	IIIc	42	264	10 months until death
8	Serous cystadenocarcinoma NOS	IIIc	58	490	2 years 8 months^a

ISSN: 1476-4598